Today: 1 May 2026
Costco stock jumps after December sales climb — what matters before Friday’s openNEW YORK
9 January 2026
1 min read

Costco stock jumps after December sales climb — what matters before Friday’s openNEW YORK

Jan 9, 2026, 05:17 EST — Premarket

  • Costco shares jumped in the prior session after a December sales update.
  • Online-linked sales outpaced the chain’s overall growth rate in the month.
  • U.S. jobs data due Friday could set the tone for consumer-facing stocks.

Costco Wholesale Corp’s (COST.O) shares rose 3.7% on Thursday to $915.31 after the warehouse retailer reported December sales results.

The monthly report matters because it lands between earnings and can quickly reset expectations for traffic, pricing and renewal-driven demand. Costco’s numbers are also watched as a bellwether for big-box retailers including Walmart and Target, and for warehouse rival BJ’s Wholesale Club.

The move shows how tightly investors are trading the story right now. Costco has been priced for steady growth, so any sign that sales are bending — up or down — can swing the stock hard.

Costco said net sales rose 8.5% to $29.86 billion in the five-week retail month ended Jan. 4, with comparable sales — sales at stores open at least a year — up 7.0% overall. Digitally-enabled comparable sales, which include orders tied to online and other digital channels, climbed 18.9%; excluding gasoline prices and currency swings, total comparable sales rose 6.2%, the company said. Costco said it operates 923 warehouses worldwide and will post a recorded message discussing the sales figures through Jan. 14.

“December sales provide a measure of relief, confirming a reacceleration in sales at a pace that are clearly gaining share,” Evercore ISI analyst Greg Melich wrote in a note on Thursday. Barron’s

Jefferies analyst Corey Tarlowe described the monthly sales print as a positive sign for the durability of Costco’s membership model, according to Seeking Alpha.

Macro risks are still sitting on the tape. The U.S. employment report is due at 8:30 a.m. ET, and economists expect payroll gains of about 60,000 in December with the unemployment rate seen edging down to 4.5%, a Reuters poll showed.

But the downside case has not gone away: Costco’s valuation leaves less margin for error if growth slows after the holidays or if costs bite. Some investors have also talked up the possibility of a stock split or another special dividend — Costco last paid a special dividend in early 2024 — but those are not company announcements and can fade quickly when the data softens.

The next hard catalyst is earnings. Costco is expected to report fiscal second-quarter results on March 5, with investors watching renewal trends, margins and whether online growth keeps outrunning store sales.

Stock Market Today

  • Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK
    May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines and capital strategies amid challenging market conditions.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 12:16 AM EDT Avalyn Pharma upsizes IPO to $300 million, Alector halts study with GSK May 1, 2026, 12:10 AM EDT. Avalyn Pharma, a Boston-based biotech, is raising $300 million by selling 16.5 million shares at $18 each in an upsized initial public offering (IPO). The capital raise aims to fund its drug development programs. Separately, Alector, in partnership with GlaxoSmithKline (GSK), has terminated another clinical study, though further details remain limited. These moves reflect ongoing volatility and strategic shifts within the biotech sector as firms adjust pipelines
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Alibaba stock (BABA) slips premarket as Nvidia H200 approval talk swirls in China
Previous Story

Alibaba stock (BABA) slips premarket as Nvidia H200 approval talk swirls in China

Tesco PLC stock slips again after Christmas update — what traders watch next
Next Story

Tesco PLC stock slips again after Christmas update — what traders watch next

Go toTop